{
    "Trade/Device Name(s)": [
        "FreeStyle Blood Glucose Test Strips",
        "FreeStyle 3 Blood Glucose Monitoring System",
        "FreeStyle 5 Blood Glucose Monitoring System",
        "FreeStyle Flash Blood Glucose Monitoring System",
        "FreeStyle Freedom Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Abbott Laboratories (Abbott Diabetes Care, Inc.)",
    "510(k) Number": "K092638",
    "Predicate Device Reference 510(k) Number(s)": [
        "K992684",
        "K000582",
        "K012014",
        "K031260",
        "K051839"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR",
        "JJX"
    ],
    "Summary Letter Date": "June 15, 2010",
    "Summary Letter Received Date": "June 07, 2009",
    "Submission Date": "June 05, 2009",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose Test System",
        "Single Analyte Control Solution"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FreeStyle 3 Blood Glucose Monitoring System",
        "FreeStyle 5 Blood Glucose Monitoring System",
        "FreeStyle Flash Blood Glucose Monitoring System",
        "FreeStyle Freedom Blood Glucose Monitoring System"
    ],
    "Method(s)/Technology(ies)": [
        "Coulometric biosensor",
        "Electrochemical biosensor"
    ],
    "Methodologies": [
        "Quantitative measurement of glucose"
    ],
    "Submission Type(s)": [
        "Test strip",
        "Monitoring System",
        "Reagent",
        "Quality control solution",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for FreeStyle Blood Glucose Test Strips and associated blood glucose monitoring systems for quantitative glucose measurement in capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in capillary whole blood from finger, upper arm, and palm by healthcare professionals and people with diabetes mellitus at home as an aid in monitoring the effectiveness of a diabetes control program; not intended for diagnosis or screening of diabetes mellitus, use on neonates, or arterial blood.",
    "fda_folder": "Clinical Chemistry"
}